Prof Sir Munir Pirmohamed, Chair of the Commission on Human Medicines, said the gains from getting vaccinated were clear: “Given the extremely rare rate of occurrence of these events, the benefits of the AstraZeneca vaccine, with the latest data suggesting an 80% reduction in hospitalisation and death from Covid disease, far outweigh any possible risks of the vaccine in the risk groups currently targeted in the UK.”
AstraZeneca: UK clot review confirms safety of vaccine
